EverHint Signal — Momentum Swing: Pullback Standard — December 10, 2025

What This Signal Is (Quick)

This scanner identifies pullback opportunities in established uptrends—stocks that dipped below their 21-day moving average (MA21) and then reclaimed it with volume confirmation. This is the classic "buy-the-dip" setup that swing traders look for.

The Pattern: A stock in an uptrend experiences short-term weakness, pulling back below MA21. Instead of continuing lower, buyers step in with increased volume, pushing price back above the moving average. This reclaim signals that the pullback is complete and the uptrend may resume.

Why It Works:

• The MA21 acts as dynamic support in trending markets
• Dips below it flush out weak hands and create lower-risk entries
• Volume confirmation shows institutions aren't bailing—they're buying
• Lower entry point = better risk/reward compared to chasing highs

Key Criteria:

• Market Cap: $1B+ (liquid, quality names)
• Volume: 1.5x+ average (confirmation required)
• Price Action: Reclaimed MA21 after dipping below it
• Holding Period: 1-4 weeks (swing trading timeframe)

This is not mean reversion like the Dip & Bounce strategy. These are momentum plays that had healthy corrections. The trend is intact—you're just buying at a temporary discount. This is experimental and works best when the broader market is trending higher.

How We Ranked Today (Reader Version)

Signals are ranked by composite quality score (0-100 scale), which considers:

• Momentum across multiple timeframes (10, 21, 63 days)
• Relative strength vs S&P 500
• Volume thrust magnitude
• Distance from 52-week high

Higher scores = cleaner pullback setups with stronger trend confirmation. We've overlaid:

• Insider Net (USD): Net insider buying/selling over 90 days. Positive = management buying the dip (bullish). Negative = insiders selling (concern).
• Days → Earnings: Time until next earnings. < 7 days = volatility risk. > 30 days = clean runway.
• % of 52W High: How close to highs. 96%+ = strong trend. < 90% = deeper pullback.

Important: These signals are for educational use and back-testing. This is an experimental scanner, not financial advice. Always do your own research.

📈 Pullback Signals (6 Signals)

Stocks that dipped below MA21 and reclaimed it with volume.

Field Notes:

• Score: NVST earns perfect 100—ideal pullback setup with all criteria met. SXI at 74, JBTM at 54. SPXC at 0 suggests weaker setup.
• Vol Thrust: JBTM leads at 2.76x (176% above average). ABVX at 2.42x, NVST at 2.29x. All showing strong institutional interest.
• % of 52W High: NVST and SXI at exactly 100%—reclaimed highs after pullback. JPM at 96.8%, SPXC at 97.0%. All near recent peaks.
• Insider Net: JPM -$301K (VP of HR sold shares Nov 7). JBTM -$19K (Director sold Dec 1). Both negative but small amounts.
• Days to Earnings: JPM reports in 42 days (clean runway). NVST in 56 days. ABVX in 48 days. All have clean paths ahead.

Recent Headlines (Last 3 Days)

JPM (JPMorgan Chase) — Major News:

• Expense Warning Tanks Stock: Consumer banking chief Marianne Lake warned Dec 9 that 2026 expenses will hit $105B—$9B+ higher than expected. Stock fell 5%.
• Hired Todd Combs from Berkshire: Dec 8, JPM hired Buffett's lieutenant Todd Combs (former Geico CEO) to head $10B Security & Resiliency Initiative.
• Q4 Guidance: Expects investment banking revenue up low-single digits, markets revenue up low-teens. Declared quarterly dividend Dec 9.
• AI Comments: CEO Dimon said AI will boost productivity and cut jobs. Also said blockchain is "real" and becoming more effective.
• 2026 Alternatives Outlook: Released global alternatives report highlighting opportunities in private markets amid AI boom.
• Volumes jumped as investors repositioned ahead of Fed rate decision Dec 10.

ABVX (Abivax) — Takeover Speculation:

• Eli Lilly rumors: French biotech's shares jumped 20% in France, 11% in US on Dec 10 on Reuters report of potential Eli Lilly takeover bid.
• Neither Abivax nor Eli Lilly have confirmed the reports.
• Motley Fool highlighted ABVX as "under-the-radar stock that soared this year"—growth story "might just be getting started."

NVST (Envista Holdings):

• No major recent news. Clean breakout at 100% of 52W high after pullback.

SXI (Standex International):

• No major recent news. Steady performer at fresh highs.

JBTM (JBT Marel):

• Director sold $18.5K in shares Nov 26 at $142.51.

SPXC (SPX Technologies):

• No major recent news.

Vlad's Take (EverHint)

Today delivered just 6 pullback signals—a small batch but high quality. These aren't random dips—these are stocks in established uptrends that briefly wobbled, tested support at MA21, and bounced back with volume. This is the setup swing traders dream about: lower-risk entries in confirmed trends.

Market Backdrop: S&P 500 +0.78%, Nasdaq +0.50%, Dow +1.02%—green across the board. VIX dropped 6.9% to 15.77, signaling calm, low-volatility conditions. Russell 2000 +1.39% shows broad market strength and risk-on behavior. Treasury yields mixed (10Y flat at 4.19%), Bitcoin $92.6K, gold +0.44%. This is a supportive environment for swing trading pullbacks.

Why Small Signal Count Matters:

Six signals isn't a problem—it's actually a feature. When this scanner only fires on a handful of stocks, it means:

1. Quality over quantity - Only the best setups make the cut
2. Market selectivity - Most stocks aren't pulling back because they're still trending
3. Focused opportunity set - Easier to research and monitor 6 names than 50

JPM — The Standout Story:

JPMorgan is the most interesting signal here. The stock fell 5% on Dec 9 after the expense warning, briefly dropped below MA21, then reclaimed it Dec 10 with 1.80x volume. This is textbook pullback behavior:

• Bad news creates panic selling
• Stock tests key support (MA21)
• Institutions step in and buy the dip
• Volume confirms the bounce

The $105B expense number spooked traders, but context matters: JPM is investing heavily in AI, tech infrastructure, and growth initiatives. These aren't wasted expenses—they're positioning for the future. The stock is at $310.17, just 3.2% below its 52-week high. Trend is intact.

ABVX — Pure Speculation:

Abivax surging on Eli Lilly rumors is a different animal. This is not a fundamental setup—it's pure M&A speculation. If the deal happens, $150+ is likely. If it's just noise, revert to $100. High risk, high reward. Not for conservative portfolios.

NVST — Perfect Score Setup:

Envista earns the top score with all boxes checked:

• 2.29x volume thrust
• 100% of 52-week high (fresh highs after pullback)
• Clean trend alignment
• 56 days to earnings (no event risk)

This is the textbook example of what we're looking for in a pullback trade.

Trading Strategy for Pullbacks:

1. Entry timing: Don't chase the reclaim. Let the stock close above MA21, then enter on the next day if it holds.
2. Stop placement: Set stops 2-3% below MA21. If the pullback fails and MA21 breaks, exit immediately.
3. Position sizing: Pullbacks are lower risk than breakouts, so you can size up slightly (2-3% of portfolio per signal).
4. Profit targets: Look for 5-10% gains or a move back to 52-week highs. Pullbacks often snap back quickly.
5. Time horizon: Hold 1-4 weeks. If the trend resumes, let it run. If it stalls, move on.

Sector Analysis:

The signals are split:

• Industrials (3): SXI, JBTM, SPXC
• Healthcare (2): NVST, ABVX
• Financial Services (1): JPM

Industrials dominance suggests manufacturing/industrial strength. No Tech signals—that sector is either breaking out or not pulling back yet.

Risk Warning:

Pullback strategies fail when the broader trend breaks. If the market rolls over and MA21 fails to hold, these signals become knife-catches. Today's low VIX and strong breadth suggest the trend is intact, but conditions change fast. Always use stops.

🚀 If this gave you insight, a quick like, share, or subscribe supports the continued work behind EverHint.

Independent, data-driven signals.
No hype. No promotions. Zero bias. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/